Tesamorelin

Tesamorelin - 5mg

Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.

$64.99

4 People recently viewed this product and 1 people have it in their cart!

25 in stock (can be backordered)

Quantity Quantity Discounts
2 - 5 $59.99
6 - 10 $56.99
11 - 19 $53.99
20 + $49.99
Get it shipped by Monday, Apr 03 , Order in next

3rd Party Tested
All of our products and batches are analyzed and tested by independent 3rd party laboratories for purity and quality assurance.

Delivery Guarantee
We guarantee the safe arrival of your package. If for any reason your package doesn’t arrive, please contact us and we will work with you to ensure you get your products in a timely fashion.

Lyophilized Powder
Lyophilization is defined as a freeze-drying process that removes water from a product after it is frozen and placed under a vacuum.

USA > $150
U.S. orders over $150 ship free, usually within one to two business days.

Discreet Shipping
All items are discreetly shipped in order to protect the privacy of our customers.

SKU tesamorelin Categories , Tags , , , ,

Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.

Additional information

Weight .291 g

Synonyms

Egrifta

Appearance

Lyophilized Powder

CAS #

901758-09-6

Structure

Sequence

Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu

Molecular Formula

C221H366N72O67S

Molecular Weight

5136 g/mol

Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.

Additional information

Weight .291 g

Synonyms

Egrifta

Appearance

Lyophilized Powder

CAS #

901758-09-6

Structure

Sequence

Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu

Molecular Formula

C221H366N72O67S

Molecular Weight

5136 g/mol

Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.

Additional information

Weight .291 g

Synonyms

Egrifta

Appearance

Lyophilized Powder

CAS #

901758-09-6

Structure

Sequence

Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu

Molecular Formula

C221H366N72O67S

Molecular Weight

5136 g/mol

Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.

Additional information

Weight .291 g

Synonyms

Egrifta

Appearance

Lyophilized Powder

CAS #

901758-09-6

Structure

Sequence

Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu

Molecular Formula

C221H366N72O67S

Molecular Weight

5136 g/mol

Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.

Additional information

Weight .291 g

Synonyms

Egrifta

Appearance

Lyophilized Powder

CAS #

901758-09-6

Structure

Sequence

Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu

Molecular Formula

C221H366N72O67S

Molecular Weight

5136 g/mol

Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.

Additional information

Weight .291 g

Synonyms

Egrifta

Appearance

Lyophilized Powder

CAS #

901758-09-6

Structure

Sequence

Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu

Molecular Formula

C221H366N72O67S

Molecular Weight

5136 g/mol

Tesamorelin is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction fat mass.

Additional information

Weight .291 g

Synonyms

Egrifta

Appearance

Lyophilized Powder

CAS #

901758-09-6

Structure

Sequence

Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu

Molecular Formula

C221H366N72O67S

Molecular Weight

5136 g/mol

Reviews(1)

There are no reviews yet.

Add a Review

Be the first to review “Tesamorelin – 5mg”

Tesamorelin – 5mg